Search

everythinglearnresearchcommunity

for

Search:↓

Nab-paclitaxel is as effective as cisplatin but safer for early-stage cervical cancer treatment.

Blocking mTORC1 reduces skin tumor growth in mice.

Provenge extends prostate cancer survival by about 4 months.

Pulsed electric field treatment may help shrink untreated liver tumors.

New molecules can prevent cell death in hair follicles.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

A new method quickly detects hair changes from EGFR inhibitors using a microscope.

GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Most patients experienced significant but reversible hair loss during treatment.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Lasers can help reduce skin side effects from cancer treatment.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Using cetirizine on the skin and taking vitamin D can help increase hair growth in children with hair loss from ectodermal dysplasia.

Erlotinib can cause hair loss and texture changes.

Erlotinib can cause excessive eyelash growth.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Topical cetirizine 1% increases hair density and may be a promising treatment for hair loss.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.